We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Advisory Committee to Discuss New Avastin Indication
Advisory Committee to Discuss New Avastin Indication
November 9, 2007
The FDA’s Oncologic Drugs Advisory Committee will meet Dec. 5 to discuss a new indication for Genentech’s breast cancer drug Avastin.